The CADENCE pilot trial - Promoting physical activity in bladder cancer survivors: A protocol paper.
Bladder cancer
Cancer survivor
Co-design intervention
Home-based exercise
Journal
Contemporary clinical trials communications
ISSN: 2451-8654
Titre abrégé: Contemp Clin Trials Commun
Pays: Netherlands
ID NLM: 101671157
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
21
01
2021
revised:
01
06
2021
accepted:
13
06
2021
entrez:
1
7
2021
pubmed:
2
7
2021
medline:
2
7
2021
Statut:
epublish
Résumé
Participation in physical activity has been found to be beneficial for mental and physical health outcomes among cancer survivors. However, to date no intervention exists specifically to promote physical activity among bladder cancer survivors. In light of this knowledge a home-based exercise intervention was co-created for those recently diagnosed with bladder cancer. The aim of the present study, financially supported by Action Bladder Cancer UK [1], is to pilot the home-based exercise intervention tailored specifically for bladder cancer survivors (i.e. from the point of diagnosis) to improve physical and mental health outcomes (during treatment and beyond) in this population. This study will use a randomised controlled trial design. Arm one will consists of the 14 week home-based exercise intervention and arm two usual care (15 participants will be randomised to each arm). Baseline data collection will take place shortly after clinical diagnosis of bladder cancer, and follow-up approximately 7 weeks and then again approximately 14 weeks after commencement of the intervention. At each data collection point data will be collected from participants relating to demographics, physical and mental health. Participants will aslo be asked to wear an Actigraph Accelerometer at each data collection point for seven consecutive days. Immediately after baseline data collection participants in the intervention arm will be given the home-based exercise booklet. Ethical approval was obtained for the present study via The London- City and East Research Ethics Committee (ID:291676). Results of this study will be disseminated through peer-reviewed publications and scientific presentations.
Sections du résumé
BACKGROUND
BACKGROUND
Participation in physical activity has been found to be beneficial for mental and physical health outcomes among cancer survivors. However, to date no intervention exists specifically to promote physical activity among bladder cancer survivors. In light of this knowledge a home-based exercise intervention was co-created for those recently diagnosed with bladder cancer.
AIM
OBJECTIVE
The aim of the present study, financially supported by Action Bladder Cancer UK [1], is to pilot the home-based exercise intervention tailored specifically for bladder cancer survivors (i.e. from the point of diagnosis) to improve physical and mental health outcomes (during treatment and beyond) in this population.
METHODS
METHODS
This study will use a randomised controlled trial design. Arm one will consists of the 14 week home-based exercise intervention and arm two usual care (15 participants will be randomised to each arm). Baseline data collection will take place shortly after clinical diagnosis of bladder cancer, and follow-up approximately 7 weeks and then again approximately 14 weeks after commencement of the intervention. At each data collection point data will be collected from participants relating to demographics, physical and mental health. Participants will aslo be asked to wear an Actigraph Accelerometer at each data collection point for seven consecutive days. Immediately after baseline data collection participants in the intervention arm will be given the home-based exercise booklet.
ETHICS AND DISSEMINATION
BACKGROUND
Ethical approval was obtained for the present study via The London- City and East Research Ethics Committee (ID:291676). Results of this study will be disseminated through peer-reviewed publications and scientific presentations.
Identifiants
pubmed: 34195472
doi: 10.1016/j.conctc.2021.100809
pii: S2451-8654(21)00110-1
pmc: PMC8239430
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100809Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Prev Chronic Dis. 2018 May 24;15:E65
pubmed: 29806579
J Pain Symptom Manage. 1997 Feb;13(2):63-74
pubmed: 9095563
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420917462
pubmed: 32476493
Sex Med. 2018 Jun;6(2):75-89
pubmed: 29661646
BMJ. 2012 Jan 30;344:e70
pubmed: 22294757
Cancer. 2019 Mar 1;125(5):798-806
pubmed: 30516839
Nutr Clin Pract. 2014 Dec;29(6):768-79
pubmed: 25335787